论文部分内容阅读
目的:对于妊娠期高血压综合征的患者应用硫酸镁与硝苯地平联合治疗的方式进行相关的研究。方法:就2015年09月01日至2016年09月01日来到我院就诊的98例妊娠期高血压综合征的患者进行实验研究。将98例妊娠期高血压综合征的患者分为两组,其中干预组患者实施硫酸镁与硝苯地平联合治疗的方式,对照组患者实施硫酸镁的治疗方式。同时,对比2组患者的临床治疗效果以及不良反应情况。结果:研究结果显示,干预组患者中仅有1例患者经治疗后无效,而对照组患者中有6例患者经治疗后无效(P<0.05),差异具有统计学意义。同时,干预组患者中有4例患者出现不良反映情况,而对照组患者中有8例患者出现了不良反应情况(P<0.05),差异具有统计学意义。结论:通过实验得出结论,使用硫酸镁与硝苯地平联合治疗妊娠期高血压综合征的效果显著,其不仅能够提高临床治疗效果,而且还能够有效的降低不良反应发生率。
OBJECTIVE: To study the way of combined treatment of magnesium sulfate and nifedipine in patients with gestational hypertension. Methods: A total of 98 patients with gestational hypertension (Hypertension Syndrome) who came to our hospital from September 1, 2015 to September 1, 2016 were studied. 98 cases of pregnancy-induced hypertension syndrome were divided into two groups, the intervention group patients with magnesium sulfate and nifedipine combined treatment, the control group of patients with magnesium sulfate treatment. At the same time, compared the clinical efficacy and adverse reactions in two groups of patients. RESULTS: The results showed that only 1 patient in the intervention group was ineffective after treatment, whereas 6 patients in the control group were ineffective (P <0.05) after treatment, with statistically significant differences. At the same time, 4 patients in the intervention group showed adverse reactions, while 8 patients in the control group showed adverse reactions (P <0.05), the difference was statistically significant. Conclusion: The results of the experiment concluded that the use of magnesium sulfate and nifedipine in the treatment of pregnancy-induced hypertension syndrome has a significant effect, which not only can improve the clinical treatment effect, but also can effectively reduce the incidence of adverse reactions.